Treatment patterns and standardized outcome assessments among patients with inflammatory conditions of the pouch in a prospective multicenter registry
Crohns & Colitis 360
Open Access Publication
Rights and Permissions
Edward L Barnes, MD, MPH, Parakkal Deepak, MBBS, MS, Poonam Beniwal-Patel, MD, Laura Raffals, MD, Maia Kayal, MD, Marla Dubinsky, MD, Shannon Chang, MD, Peter D R Higgins, MD, PhD, Jennifer I Barr, BA, Joseph Galanko, PhD, Yue Jiang, PhD, Raymond K Cross, MD, MS, Millie D Long, MD, MPH, Hans H Herfarth, MD, PhD, Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry, Crohn's & Colitis 360, Volume 4, Issue 3, July 2022, otac030, https://doi.org/10.1093/crocol/otac030. © The Author(s) 2022. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (https://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact email@example.com.
Barnes, Edward L; Deepak, Parakkal; Beniwal-Patel, Poonam; Raffals, Laura; Kayal, Maia; Dubinsky, Marla; Chang, Shannon; Higgins, Peter D R; Barr, Jennifer I; Galanko, Joseph; Jiang, Yue; Cross, Raymond K; Long, Millie D; and Herfarth, Hans H, "Treatment patterns and standardized outcome assessments among patients with inflammatory conditions of the pouch in a prospective multicenter registry." Crohns & Colitis 360. 4, 3. otac030 (2022).
Supplementary Methods; SUPPLEMENTARY REFERENCES; Supplementary Table 1. Enrollment of Study Participants by Center; Supplementary Table 2. Frequency of Diagnostic Criteria for Utilized in the Assessment of Patients Enrolled in PROP-RD; Supplementary Table 3. Medication use prior to colectomy among patients enrolled in PROP-RD; Supplementary Table 4. Comparison of laboratory data at enrollment among patients with inflammatory conditions of the pouch; Supplementary Table 5a. Clinical assessments at 6 months after enrollment, stratified by disease state and baseline remission status; Supplementary Table 5b. Clinical assessments at 6 months after enrollment, stratified by disease state and baseline remission status; Supplementary Table 6. Antibiotic usage patterns at enrollment among patients in clinical remission at 6 months after enrollment, stratified by inflammatory condition of the pouch; Supplementary Table 7. Proportion of patients in clinical remission, stratified by treatment regimen and disease activity at enrollment